Shannon Kelly

ORCID: 0000-0003-2049-3992
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Hemoglobinopathies and Related Disorders
  • Iron Metabolism and Disorders
  • Genetic Associations and Epidemiology
  • Blood groups and transfusion
  • Epigenetics and DNA Methylation
  • Erythrocyte Function and Pathophysiology
  • Telomeres, Telomerase, and Senescence
  • Genomics and Rare Diseases
  • Acute Myeloid Leukemia Research
  • Prenatal Screening and Diagnostics
  • RNA modifications and cancer
  • Genetic Mapping and Diversity in Plants and Animals
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Genomics and Chromatin Dynamics
  • Bioinformatics and Genomic Networks
  • Single-cell and spatial transcriptomics
  • HIV Research and Treatment
  • Cancer Genomics and Diagnostics
  • Genetic and phenotypic traits in livestock
  • T-cell and B-cell Immunology
  • Parvovirus B19 Infection Studies
  • Genetic factors in colorectal cancer
  • Folate and B Vitamins Research
  • Smoking Behavior and Cessation
  • Genomic variations and chromosomal abnormalities

Pacific Research Institute
2019-2025

Vitalant
2019-2025

UCSF Benioff Children's Hospital
2016-2025

University of California, San Francisco
2016-2025

NHS Lanarkshire
2024

University of the West of Scotland
2024

University of San Francisco
2022-2023

Kelly Services (United States)
2023

Fundação Centro de Hematologia e Hemoterapia de Minas Gerais
2023

Universidade de São Paulo
2023

Daniel Taliun Daniel Harris Michael D. Kessler Jedidiah Carlson Zachary A. Szpiech and 95 more Raúl Torres Sarah A. Gagliano Taliun André Corvelo Stephanie M. Gogarten Hyun Min Kang Achilleas Pitsillides Jonathon LeFaive Seung‐been Lee Xiaowen Tian Brian L. Browning Sayantan Das Anne‐Katrin Emde Wayne E. Clarke Douglas P. Loesch Amol C. Shetty Thomas W. Blackwell Albert V. Smith Quenna Wong Xiaoming Liu Matthew P. Conomos Dean Bobo François Aguet Christine M. Albert Álvaro Alonso Kristin Ardlie Dan E. Arking Stella Aslibekyan Paul L. Auer John Barnard R. Graham Barr Lucas Barwick Lewis C. Becker Rebecca Beer Emelia J. Benjamin Lawrence F. Bielak John Blangero Michael Boehnke Donald W. Bowden Jennifer A. Brody Esteban G. Burchard Brian E. Cade James F. Casella Brandon Chalazan Daniel I. Chasman Yii‐Der Ida Chen Michael H. Cho Seung Hoan Choi Mina K. Chung Clary B. Clish Adolfo Correa Joanne E. Curran Brian Custer Dawood Darbar Michelle Daya Mariza de Andrade Dawn L. DeMeo Susan K. Dutcher Patrick T. Ellinor Leslie Emery Celeste Eng Diane Fatkin Tasha E. Fingerlin Lukas Forer Myriam Fornage Nora Franceschini Christian Fuchsberger Stephanie M. Fullerton Søren Germer Mark T. Gladwin Daniel J. Gottlieb Xiuqing Guo Michael E. Hall Jiang He Nancy L. Heard‐Costa Susan R. Heckbert Marguerite R. Irvin Jill M. Johnsen Andrew D. Johnson Robert C. Kaplan Sharon L. R. Kardia Tanika N. Kelly Shannon Kelly Eimear E. Kenny Douglas P. Kiel Robert Klemmer Barbara A. Konkle Charles Kooperberg Anna Köttgen Leslie A. Lange Jessica Lasky‐Su Daniel Levy Xihong Lin Keng‐Han Lin Chunyu Liu Ruth J. F. Loos

Abstract The Trans-Omics for Precision Medicine (TOPMed) programme seeks to elucidate the genetic architecture and biology of heart, lung, blood sleep disorders, with ultimate goal improving diagnosis, treatment prevention these diseases. initial phases focused on whole-genome sequencing individuals rich phenotypic data diverse backgrounds. Here we describe TOPMed goals design as well available resources early insights obtained from sequence data. include a variant browser, genotype...

10.1038/s41586-021-03205-y article EN cc-by Nature 2021-02-10
Daniel Taliun Daniel Harris Michael D. Kessler Jedidiah Carlson Zachary A. Szpiech and 95 more Raúl Torres Sarah A. Gagliano Taliun André Corvelo Stephanie M. Gogarten Hyun Min Kang Achilleas Pitsillides Jonathon LeFaive Seung‐been Lee Xiaowen Tian Brian L. Browning Sayantan Das Anne‐Katrin Emde Wayne E. Clarke Douglas P. Loesch Amol C. Shetty Thomas W. Blackwell Quenna Wong François Aguet Christine M. Albert Álvaro Alonso Kristin Ardlie Stella Aslibekyan Paul L. Auer John Barnard R. Graham Barr Lewis C. Becker Rebecca Beer Emelia J. Benjamin Lawrence F. Bielak John Blangero Michael Boehnke Donald W. Bowden Jennifer A. Brody Esteban G. Burchard Brian E. Cade James F. Casella Brandon Chalazan Yii‐Der Ida Chen Michael H. Cho Seung Hoan Choi Mina K. Chung Clary B. Clish Adolfo Correa Joanne E. Curran Brian Custer Dawood Darbar Michelle Daya Mariza de Andrade Dawn L. DeMeo Susan K. Dutcher Patrick T. Ellinor Leslie Emery Diane Fatkin Lukas Forer Myriam Fornage Nora Franceschini Christian Fuchsberger Stephanie M. Fullerton Søren Germer Mark T. Gladwin Daniel J. Gottlieb Xiuqing Guo Michael E. Hall Jiang He Nancy L. Heard‐Costa Susan R. Heckbert Marguerite R. Irvin Jill M. Johnsen Andrew D. Johnson Sharon L. R. Kardia Tanika N. Kelly Shannon Kelly Eimear E. Kenny Douglas P. Kiel Robert Klemmer Barbara A. Konkle Charles Kooperberg Anna Köttgen Leslie A. Lange Jessica Lasky‐Su Daniel Levy Xihong Lin Keng‐Han Lin Chunyu Liu Ruth J. F. Loos Lori Garman Robert E. Gerszten Steven A. Lubitz Kathryn L. Lunetta Angel C. Y. Mak Ani Manichaikul Alisa K. Manning Rasika A. Mathias David D. McManus Stephen T. McGarvey

Summary paragraph The Trans-Omics for Precision Medicine (TOPMed) program seeks to elucidate the genetic architecture and disease biology of heart, lung, blood, sleep disorders, with ultimate goal improving diagnosis, treatment, prevention. initial phases focus on whole genome sequencing individuals rich phenotypic data diverse backgrounds. Here, we describe TOPMed goals design as well resources early insights from sequence data. include a variant browser, genotype imputation panel, sharing...

10.1101/563866 preprint EN cc-by bioRxiv (Cold Spring Harbor Laboratory) 2019-03-06
Tetsushi Nakao Alexander G. Bick Margaret A. Taub Seyedeh M. Zekavat Md Mesbah Uddin and 95 more Abhishek Niroula Cara L. Carty John Lane Michael C. Honigberg Joshua S. Weinstock Akhil Pampana Christopher J. Gibson Gabriel K. Griffin Shoa L. Clarke Romit Bhattacharya Themistocles L. Assimes Leslie Emery Adrienne M. Stilp Quenna Wong Jai Broome Cecelia Laurie Alyna Khan Albert V. Smith Thomas W. Blackwell Veryan Codd Christopher P. Nelson Zachary T. Yoneda Juan M. Peralta Donald W. Bowden Marguerite R. Irvin Meher Preethi Boorgula Wei Zhao Lisa R. Yanek Kerri L. Wiggins James E. Hixson C. Charles Gu Gina M. Peloso Dan M. Roden Muagututi‘a Sefuiva Reupena Chii‐Min Hwu Dawn L. DeMeo Kari E. North Shannon Kelly Solomon K. Musani Joshua C. Bis Donald M. Lloyd‐Jones Jill M. Johnsen Michael Preuß Russell P. Tracy Patricia A. Peyser Dandi Qiao Pinkal Desai Joanne E. Curran Barry I. Freedman Hemant K. Tiwari Sameer Chavan Jennifer A. Smith Nicholas L. Smith Tanika N. Kelly Bertha Hidalgo L. Adrienne Cupples Daniel E. Weeks Nicola L. Hawley Ryan L. Minster Ranjan Deka Take Naseri Lisa de las Fuentes Laura M. Raffield Alanna C. Morrison Paul S. de Vries Christie M. Ballantyne Eimear E. Kenny Stephen S. Rich Eric A. Whitsel Michael H. Cho M. Benjamin Shoemaker Betty S. Pace John Blangero Nicholette D. Palmer Braxton D. Mitchell Alan R. Shuldiner Kathleen C. Barnes Susan Redline Sharon L.R. Kardia Gonçalo R. Abecasis Lewis C. Becker Susan R. Heckbert Jiang He Wendy S. Post Donna K. Arnett Ramachandran S. Vasan Dawood Darbar Scott T. Weiss Stephen T. McGarvey Mariza de Andrade Yii‐Der Ida Chen Robert C. Kaplan Deborah A. Meyers Brian Custer Adolfo Correa

Human genetic studies support an inverse causal relationship between leukocyte telomere length (LTL) and coronary artery disease (CAD), but directionally mixed effects for LTL diverse malignancies. Clonal hematopoiesis of indeterminate potential (CHIP), characterized by expansion hematopoietic cells bearing leukemogenic mutations, predisposes both hematologic malignancy CAD. TERT (which encodes telomerase reverse transcriptase) is the most significantly associated germline locus CHIP in...

10.1126/sciadv.abl6579 article EN cc-by-nc Science Advances 2022-04-06

Genotype-phenotype association studies often combine phenotype data from multiple to increase statistical power. Harmonization of the usually requires substantial effort due heterogeneity in definitions, study design, collection procedures, and data-set organization. Here we describe a centralized system for harmonization that includes input domain experts, quality control, documentation, reproducible results, data-sharing mechanisms. This was developed National Heart, Lung, Blood...

10.1093/aje/kwab115 article EN cc-by-nc American Journal of Epidemiology 2021-04-14

BACKGROUNDCurative gene therapies for sickle cell disease (SCD) are currently undergoing clinical evaluation. The occurrence of myeloid malignancies in these trials has prompted safety concerns. Individuals with SCD predisposed to malignancies, but the underlying causes remain undefined. Clonal hematopoiesis (CH) is a premalignant condition that also confers significant predisposition cancers. While it been speculated CH may play role SCD-associated cancer predisposition, limited data...

10.1172/jci156060 article EN cc-by Journal of Clinical Investigation 2022-01-06

Abstract Background Red cell alloimmunization remains a challenge for individuals with sickle disease (SCD) and contributes to increased risk of hemolytic transfusion reactions associated comorbidities. Despite prophylactic serological matching ABO, Rh, K, red persists, in part, due high frequency variant RH alleles patients SCD Black blood donors. Study Design Methods We compared genotypes rates 342 pediatric young adult on chronic therapy exposed >90,000 units at five sites across the...

10.1111/trf.17740 article EN Transfusion 2024-01-30

Approximately 3500 children with sickle cell disease (SCD) are born in Brazil each year, but the burden of SCD morbidity is not fully characterised. A large, multi-centre cohort was established to characterise clinical outcomes Brazilian population and create infrastructure perform genotype-phenotype association studies. Eligible patients were randomly selected from participating sites recruited at routine visits. biorepository blood samples created comprehensive demographic outcome data...

10.1111/bjh.15462 article EN British Journal of Haematology 2018-07-19

Abstract Background The Recipient Epidemiology and Donor Evaluation Study‐IV‐Pediatric (REDS‐IV‐P) is a new iteration of prior National Heart, Lung, Blood Institute (NHLBI) REDS programs that focus on improving transfusion recipient outcomes across the lifespan as well safety availability blood supply. Study Design Methods US program includes centers hospitals (22 including 6 free‐standing Children's hospitals) in four geographic regions. Brazilian has 5 participating hemocenters. A Center...

10.1111/trf.16869 article EN Transfusion 2022-04-19

Outbreaks caused by Dengue, Zika and Chikungunya viruses can spread rapidly in immunologically naïve populations. By analysing 92 newly generated viral genome sequences from blood donors recipients, we assess the dynamics of dengue virus serotype 4 during 2012 outbreak Rio de Janeiro. Phylogenetic analysis indicates that was genotype II, although two isolates I were also detected for first time Evolutionary modelling estimates are congruent, indicating a reproduction number above 1 between...

10.1038/s41598-017-15152-8 article EN cc-by Scientific Reports 2017-11-03
Seon-Kyeong Jang Luke M. Evans Allison Fialkowski Donna K. Arnett Allison E. Ashley‐Koch and 85 more Kathleen C. Barnes Diane M. Becker Joshua C. Bis John Blangero Eugene R. Bleecker Meher P. Boorgula Donald W. Bowden Jennifer A. Brody Brian E. Cade Brenda W. Campbell Jenkins April P. Carson Sameer Chavan L. Adrienne Cupples Brian Custer Scott M. Damrauer Sean P. David Mariza de Andrade Carla Luana Dinardo Tasha E. Fingerlin Myriam Fornage Barry I. Freedman Melanie E. Garrett Sina A. Gharib David C. Glahn Jeffrey Haessler Susan R. Heckbert John E. Hokanson Lifang Hou Shih‐Jen Hwang Matthew C. Hyman Renae Judy Anne E. Justice Robert C. Kaplan Sharon L. R. Kardia Shannon Kelly Wonji Kim Charles Kooperberg Daniel Levy Donald M. Lloyd‐Jones Ruth J. F. Loos Ani Manichaikul Mark T. Gladwin Lisa W. Martin Mehdi Nouraie Olle Melander Deborah A. Meyers Courtney G. Montgomery Kari E. North Elizabeth C. Oelsner Nicholette D. Palmer Marinelle Payton Anna L. Peljto Patricia A. Peyser Michael Preuß Bruce M. Psaty Dandi Qiao Daniel J. Rader Nicholas Rafaels Susan Redline Robert M. Reed Alexander P. Reiner Stephen S. Rich Jerome I. Rotter David A. Schwartz Aladdin H. Shadyab Edwin K. Silverman Nicholas L. Smith J. G. Smith Albert V. Smith Jennifer A. Smith Weihong Tang Kent D. Taylor Marilyn J. Telen Ramachandran S. Vasan Victor R. Gordeuk Zhe Wang Kerri L. Wiggins Lisa R. Yanek Ivana V. Yang Kendra A. Young Kristin L. Young Yingze Zhang Dajiang J. Liu Matthew C. Keller Scott Vrieze

10.1038/s41562-022-01408-5 article EN Nature Human Behaviour 2022-08-04

10.1016/j.xgen.2024.100692 article EN cc-by-nc-nd Cell Genomics 2024-10-31

Hyperhemolysis syndrome (HHS) is a severe transfusion-related complication with complex immune pathophysiology, primarily affecting individuals sickle cell disease (SCD). Limited research has investigated the clinical and molecular risk factors for HHS, which could help identify at-risk patients. This study aimed to assess associated HHS genetic variations that increase susceptibility using candidate-gene approach. Data were obtained from REDS-III SCD cohort, comprising 2793 patients who...

10.1111/trf.18232 article EN Transfusion 2025-04-02

Este trabalho buscou avaliar a dinâmica de inovação em indústrias maduras olhando, especificamente, o caso da indústria brasileira Gás Liquefeito Petróleo (GLP) entre os anos 2016 e 2022. Como base análise das estratégias empresas distribuição GLP no Brasil, foram selecionados projetos agraciados com Prêmio Inovação Tecnologia, entendendo que estes constituem apenas uma amostra representativa dos esforços pesquisa desenvolvimento do setor. O objetivo artigo desmistificar ideia não configura...

10.54033/cadpedv22n6-058 article PT Caderno Pedagógico 2025-04-07

A match of HLA loci between patients and donors is critical for successful hematopoietic stem cell transplantation. However, the extreme polymorphism – an outcome millions years natural selection reduces chances that two individuals will carry identical combinations multilocus genotypes. Further, variability not homogeneously distributed throughout world: African populations on average have greater than non-Africans, reducing unrelated are identical. Here, we explore how self-identification...

10.3389/fimmu.2020.584950 article EN cc-by Frontiers in Immunology 2020-11-06

Human genetic variation has enabled the identification of several key regulators fetal-to-adult hemoglobin switching, including BCL11A, resulting in therapeutic advances. However, despite progress made, limited further insights have been obtained to provide a fuller accounting how contributes global mechanisms fetal (HbF) gene regulation. Here, we conducted multi-ancestry genome-wide association study 28,279 individuals from cohorts spanning 5 continents define architecture human impacting...

10.1101/2023.03.24.23287659 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2023-03-24

To define the prevalence of leg ulcers and identify clinical laboratory factors associated with in adult participants.The authors conducted a cross-sectional study 1,109 patients who were 18 years or older SS Sβ0-thalassemia genotypes from Brazilian cohort. Investigators assessed 2013 to 2017.The was 21%. Increasing age (odds ratio [OR], 1.07; range, 1.06-1.09), male sex (OR, 2.03; 1.44-2.87), treatment chronic transfusion therapy 1.88; 1.15-3.03), higher indirect bilirubin levels 1.48;...

10.1097/01.asw.0000911152.41719.e5 article EN Advances in Skin & Wound Care 2023-01-20

Abstract Weedy rice (Oryza spp.) is a problematic weed of cultivated (O. sativa) around the world. Recent studies have established multiple independent evolutionary origins weedy rice, raising questions about traits and genes that are essential for evolution this weed. Among world regions, South Asia stands out due to heterogeneity its populations, which can be traced at least three origins: two through de-domestication from distinct varieties, one local wild rufipogon/O. nivara). Here we...

10.1534/g3.118.200605 article EN cc-by G3 Genes Genomes Genetics 2018-10-01

Sickle cell disease (SCD) affects more than 13 million people and can have a significant impact on the quality of life (QoL) those persons. We performed cross-sectional study to evaluate QoL in SCD children 8–12 years old enrolled from November 2014 March 2016 large multicenter cohort Brazil. The PedsQL™ Module was used 412 six Brazilian health centers. mean age participants 10.5 193(46.7%) were women. global score 60.7, with Cronbach´s alpha 0.92. There differences socioeconomic...

10.1080/08880018.2019.1660743 article EN Pediatric Hematology and Oncology 2019-09-06

BACKGROUND Genetic diversity in the RH genes among sickle cell disease (SCD) patients is well described but not yet extensively explored populations of racially diverse origin. Transfusion support complicated who develop unexpected Rh antibodies. Our goal was to describe variation a large cohort Brazilian SCD exhibiting antibodies (antibodies against antigens which patient phenotypically positive) and evaluate impact using patient's genotype guide transfusion support. STUDY DESIGN AND...

10.1111/trf.15479 article EN Transfusion 2019-08-13
Coming Soon ...